Biological Material Analysis TRIZ Cases

Measuring IL-1 beta, IL-6, and IL-18 levels stratifies patients into high and low responders, resolving heterogeneity in cartilage regeneration outcomes.

Low-dose naltrexone primes cancer cells to enhance sensitivity to small molecule signaling inhibitors, addressing limited efficacy of continuous administration.

Extracting surface geometric and chemical properties filters noise from predicted structures, improving prediction reliability.

Modifying CDR regions creates selective binding that promotes tumor phagocytosis while preventing red blood cell agglutination.

Isolated macadamia proteins eliminate cross-reactivity from whole nut extracts, ensuring accurate differential diagnosis and therapy monitoring.

Low molecular weight peptides activate calcium receptors to enhance food flavors at low concentrations.

Undiluted serum bridging assay prevents antibody-antigen dissociation by maintaining native concentration, ensuring accurate free antigen quantification.

Segmenting reporting functions with distinct emission wavelengths enables simultaneous detection of multiple analytes without increasing system complexity.

Reversibly switchable fluorescent protein indicators enable dynamic calcium sensing through light-controlled brightness transitions.

Plasma cytochrome c levels indicate mitochondrial toxicity to replace invasive tissue biopsies, reducing patient discomfort and diagnostic costs.

A method calculates personalized glycemic index using real-time blood glucose concentration measurements and time-to-peak intervals.

Surface-initiated polymerization creates molecular recognition elements with fully accessible binding functions.

Segmented antibody design targets MMP9 specifically, resolving toxicity from broad-spectrum inhibition.

Antagonistic anti-EphA2 antibodies block tyrosine phosphorylation, preventing tumor cell growth driven by agonist activity.

A serum calcium biomarker panel differentiates malignant from benign adnexal masses through ionized and albumin-corrected calcium level comparisons.

A capture screen with EpCAM antibodies isolates tumor cells for multicolor fluorescence analysis.

NKp46-binding agents deplete tumor cells expressing NKp46, resolving off-target effects in peripheral T-cell lymphoma therapy.

Brachyury polypeptides resolve limited antigen availability by enabling diagnosis and treatment across multiple carcinoma types.

Freeze-drying transitions liquid suspensions into solid powders, resolving the contradiction between high brightness and storage stability.

A chromogenic medium containing specific substrates enables direct visual identification of vancomycin-resistant enterococci species from biological samples.

A blood analyzing method uses a fluorescent dye and cationic surfactant to detect piroplasm-infected red blood cells via flow cytometry.

Standardized automated imaging protocols resolve reliability issues in nematode-based cancer tests by ensuring consistent biological behavior analysis.

Replacing mass spectrometry, the sensor uses biological recognition elements to measure antibody titer and glycosylation in near real-time.

Teleost embryos detect toxicity in solvent extracts from cosmetic products.

Using soluble DPPIV/Seprase as a universal marker overcomes the high cost and low sensitivity of current imaging methods for early cancer diagnosis.

A fibrinogen assay uses antibody extraction to measure attenuance curves for automated concentration determination.

Calcium receptor activation screens kokumi peptides, resolving sensitivity and purity trade-offs.

Identify encysted cyathostomin larvae through specific antibody detection, enabling targeted treatment that delays anthelmintic resistance.

Functionalized filamentous materials capture Borrelia biomarkers from urine, enabling detection at 2.5 picograms/mL concentrations.

Acid treatment of biological specimens enables anti-chitosan antibody immunoassays, resolving insufficient detection sensitivity in early zygomycosis diagnosis.

A molecular hapten trap captures free biotin in diagnostic reagents.

TRAF2 protein captures the HCV p21 capsid directly, bypassing seroconversion delays and enabling early diagnosis without specialized equipment.

Phage display screening of recombinant Ab-Y3 variants isolates specific glycosylation patterns, overcoming analytical limitations in glycobiology research.

A covalently-linked multilayered three-dimensional molecular net captures analytes from complex samples.

Boronic acid tosyl probe immobilizes glycoproteins on a surface, exposing native glycan residues without altering their structure or inactivating the protein.

Immunomagnetic enrichment isolates circulating melanoma cells to resolve unreliable survival prediction in metastatic melanoma patients.

Centrifugal Gyrolab assay captures free C5 with strepavidin particles, preventing bound target dissociation errors during quantitation.

Phage display generates anti-BTN1A1 fragments to resolve detection accuracy and development complexity.

Segmented lateral flow strips detect Vibrio presence, activity, and virulence simultaneously, eliminating slow laboratory culture requirements.